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Rationale
• Due to their unique properties, platinum nanoparticles 
(PtNPs) hold potential for biomedical therapeutics.
• Potential applications include cancer ablation, drug 
delivery, and bio-imaging.
• Prior to their utilization as therapeutics we need to better 
understand the cellular response to PtNPs.
• The goal of this study was to elucidate the response of 
human liver cells to acute PtNP exposure, as a function 
of concentration.
• Human liver, HepG2 cell model: Liver cancer line
• 70 nm, citrate coated PtNPs: Purchased from 
nanoComposix
• Safety evaluation: Introduce PtNPs into the HepG2s at 
multiple dosages, incubate for 24 hours, then assess the 
biological response
Figure 1: Experimental Approach
• At higher dosages PtNPs were able to induce stress and inflammatory 
activation in human liver cells.
• Incubation with PtNPs increased activation of Akt.
• Taken together, these results indicate that chronic exposure could induce 
health consequences.
Methodology
Conclusions
Results
Figure 3: TEM of 
the 70 nm PtNPs
Figure 4: HepG2 (A) viability and 
(B) stress following PtNP exposure
Figure 6: Secretion levels of (A) IL-1β, IL-8, and 
TNF-α following PtNP exposure.
* Indicates statistical significance from untreated control, n=3, p<0.05
PtNPs activated 
stress, 
inflammatory, and 
signaling 
responses.
Figure 5: IGF-1 induced (A) Akt
and (B) Erk activation.  
PtNPs Culture of HepG2s
Evaluate PtNP-induced cellular consequences
• Viability
• Stress
• Cytokine secretion
• Signal Transduction
Figure 2: Images of the 
HepG2 cells (A) alone and 
(B) with PtNPs. The arrows 
indicate PtNP-HepG2 
association.
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70 nm
Primary Size (nm)
Water Media Water Media
68.3 ± 3.5 85.9 ± 3.5 112.4 ± 7.0 -40.6 ± 1.1 -12.2 ± 0.9
Agglomerate Size (nm) Zeta Potential (mV)
Table 1: PtNP Characterization Details
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